Mapping Metabolic Dysfunction-associated Steatotic Liver Disease Models of Care across 17 Middle East and North Africa Countries: Insights into Guidelines, Infrastructure, and Referral Systems

Mohamed El‐Kassas; Khalid Al‐Naamani; Rofida Khalifa; Yusuf Yılmaz; Asma Labidi; Maen Almattooq; Faisal M. Sanai; Maisam W.I. Akroush Nabil Debzi; Mohammed A. Medhat; Imam Waked; Ali Tumi; Mohamed Elbadry; Mohammed Omer Mohammed; Ala I. Sharara; Ali El Houni; Mohamed Alsenbesy; Hisham R El‐Khayat; Mina Tharwat; Abdel‐Naser Elzouki; Khalid Alswat; Zobair M. Younossi

doi:10.14218/jcth.2025.00286

Key Points

Existing models of care for steatotic liver disease vary widely across the MENA region, indicating significant gaps in healthcare delivery.
The assessment identified clinical infrastructure weaknesses and the need for updated policy frameworks to manage metabolic dysfunction effectively.
Provider perspectives revealed an urgent demand for improved guidelines to address the escalating burden of metabolic dysfunction-associated steatotic liver disease.
The findings emphasize the importance of strengthening healthcare systems to better manage steatotic liver disease in Middle Eastern and North African countries.

Implication

This observational analysis assesses models of care and clinical infrastructure for steatotic liver disease in MENA, highlighting critical policy frameworks.

Abstract

Background and AimsMetabolic dysfunction-associated steatotic liver disease (MASLD) represents an escalating healthcare burden across the Middle East and North Africa (MENA) region; however, system-level preparedness remains largely undefined. This study aimed to assess existing models of care, clinical infrastructure, policy frameworks, and provider perspectives across 17 MENA countries.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

El‐Kassas et al. (2025) studied this question.

synapsesocial.com/papers/68bb49bc6d6d5674bccff385 https://doi.org/10.14218/jcth.2025.00286

View Full Paper

Ask AI

Bookmark

Share

Mapping Metabolic Dysfunction-associated Steatotic Liver Disease Models of Care across 17 Middle East and North Africa Countries: Insights into Guidelines, Infrastructure, and Referral Systems

Key Points

Implication

Abstract

Discussion

Cite This Study

Mapping Metabolic Dysfunction-associated Steatotic Liver Disease Models of Care across 17 Middle East and North Africa Countries: Insights into Guidelines, Infrastructure, and Referral Systems

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading